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WS17.1 Recruitment of CFTR to the enterocyte apical membrane
is coordinated with internalization of the transmembrane
mucin MUC17 and secretion of the MUC2 mucin from the
goblet cells
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The small intestinal mucus is of one type and mainly consists of the goblet cell
secreted gel-forming mucin MUC2. Another type of mucins is the membrane-
tethered mucins MUC3, MUC12 and MUC17 that are anchored in the apical plasma
membrane of enterocytes. These mucins build the enterocyte glycocalyx and are
thought to protect the brush border membrane.
Secretion of the gel-forming mucin MUC2 is triggered by the cholinergic agonist
carbachol. The same stimuli cause the enterocytes to relocalize the CFTR channel
to the apical membrane to secrete chloride and bicarbonate necessary for proper
mucin unfolding and hydration. Simultaneously, the NHE exchanger is relocated
from the apical membrane to limit apical secretion of protons that should have
neutralized bicarbonate. Interestingly, at the same time the transmembrane mucin
MUC17 is also relocalized from the apical membrane into intracellular vesicles [1].
Both CFTR and MUC17 have C-terminal PDZ-binding motifs and both also bind
to the PDZ protein PDZK1. This is an adapter family protein that controls proper
localization of plasma membrane proteins by linking them to the cytoskeleton.
By using an intestinal human cell line as model system, the interaction of PDZK1
with CFTR and MUC17 is analyzed by immunoﬂuorescent co-staining and co-
immunoprecipitation of native and mutant constructs. Phospho-speciﬁc analyses of
the proteins are carried out to characterize interaction regulation due to phospho-
rylation.
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Objectives: A wide range of CFTR expressing epithelia are permanently in motion
and thus exposed to different mechanical forces. There is evidence that distension
of the pulmonary epithelium activates a Cl− secretion (Bogdan et al. 2008, Pﬂugers
Arch) and that the activity of CFTR could be inﬂuenced by mechanical forces
(Zhang et al. 2010, Nat Cell Biol). The underlying mechanisms of this activation
are currently unknown. The aim of this study was to investigate the impact of
mechanical forces on CFTR activity in native pulmonary epithelia.
Methods: Freshly dissected Xenopus laevis lungs were mounted in modiﬁed Ussing-
chambers that allowed the application of hydrostatic pressure (HP, 5 cm or 10 cm
ﬂuid-column) while changes of short-circuit current (ISC) were recorded. HP was
applied in the absence and presence of the CFTR inhibitor (GlyH-101) and a CFTR
activator (IBMX) to determine whether or not CFTR activity is inﬂuenced by HP-
induced stretch.
Results: Apical application of HP (5 cm) led to a decrease of net ion current
(11±2%). In presence of GlyH-101 the HP-induced current decrease was signif-
icantly augmented (5 cm: 28±4%; p< 0.01; 10 cm: 44±6%; p< 0.01). IBMX a
known secretagogue increased ISC, although there was no change of the HP effect
(10 cm) in comparison with controls (HP effect without IBMX; p = 0.08).
Conclusion: HP activates a Cl− secretion in native lung epithelium that is sensitive
to CFTR inhibitors but not affected by secretagogues. These data indicate that CFTR
activity is regulated by membrane stretch and that CFTR is a mechanosensitive
channel.
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Objectives: SLC26A9 (solute carrier family 26, member 9) has recently been
identiﬁed as an epithelial Cl− channel preventing mucus obstruction in airway
inﬂammation and hence might play a key role in the therapy of mucostatic airway
diseases such as cystic ﬁbrosis. The underlying molecular regulation, however, still
remains unknown.
Methods: Fischer Rat Thyroid (FRT) cells and cystic ﬁbrosis airway epithelial
cells expressing CFTR (CFBE wtCFTR) were stably transfected with a HA-
tagged SLC26A9 construct. Transepithelial Cl− currents were measured using a
Cl− gradient under isotonic and hypotonic conditions in Ussing chambers.
Results: SLC26A9 was expressed at high levels in transduced FRT (FRT-SLC) and
at moderate levels in CFBE (CFBE wtCFTR-SLC) cells. Bioelectric measurements
demonstrated that basal short circuit current (Isc) was signiﬁcantly increased in FRT-
SLC (11.9±1.9mA/cm2) compared to control FRT (FRT-CTL) (3.4±0.7mA/cm2)
cells (P< 0.05). Further, IBMX/Forskolin-stimulated Cl− secretion was signif-
icantly increased in FRT-SLC compared to FRT-CTL cells (DIsc = 2.4±0.3 to
DIsc = 0.2±0.3mA/cm2, respectively). SLC26A9-mediated currents were signiﬁ-
cantly increased under hypotonic conditions and inhibited by niﬂumic acid.
Conclusion: In summary, we established stable HA tagged-SLC26A9 overexpress-
ing epithelial cell lines for further studies of its regulation. Activation of SLC26A9-
mediated Cl− conductance in epithelial cells may require the translocation of
SLC26A9 into the plasma membrane and volume-sensing kinases (e.g. WNKs)
may be implicated in this process.
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Objectives: The functional characterization of mutations in ENaC genes, identiﬁed
in CF patients, requires a cellular model that recapitulates the physiological
interactions between ENaC and CFTR channels. To this end, we transfected FRT
(Fischer Rat Thyroid) cells, which do not express endogenous ENaC and CFTR
genes, with tagged human ENaC genes.
Methods: Mammalian expression vectors carrying the three tagged ENaC genes
were achieved for each wild-type human ENaC subunit and used to transfect
FRT cells transiently. To study ENaC activity, we measured ﬂuid absorption from
the apical side in polarized cells in the absence or in the presence of a low-
molecular weight trypsin-like protease inhibitor camostat mesylate at different doses
(0.3−30mM).
Results: Confocal microscopy showed that transfected FRT cells expressed the
subunits at high level with a cytoplasmic localization and at intercellular borders.
FRT transfected with ENaC subunits in a ratio of a:b:g of 2:1:1 showed a higher
ﬂuid absorption than non-transfected cells but lower than wt CFTR 16HBE14o−
cells, even in the presence of dexamethasone, consistent with low ENaC activity.
Nevertheless, camostat reduced signiﬁcantly the rate of ﬂuid reabsorption in
transfected cells in a dose-dependent way.
Conclusions: We have found optimal doses of camostat as inhibitor of ENaC
function in a ﬂuid absorption assay. The goal of the following work will be to
analyze transient and stable ENaC-FRT clones with CFTR expression.
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